Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials.
published in: Critical Reviews in Oncology Hematology
date of publication: 2015-04-09
language: English
main subject: endothelium, sirolimus, renal cell carcinoma
Cites articles
There is nothing here
Article - wd:Q38434143